Literature DB >> 18628074

Hodgkin's disease and intercurrent processes that may simulate a relapse.

A Sánchez1, B Cantos, P España, C Salas, M Provencio.   

Abstract

Hodgkin's disease (HD) is an example of a curable disease. In addition, it can serve as a lesson about other pathologies because of the delayed side effects it produces and the appearance of associated processes that may simulate disease progression. Here we provide a case report of a patient who encapsulates a compendium of situations that may occur in HD.

Entities:  

Mesh：

Year:  2008        PMID： 18628074     DOI： 10.1007/s12094-008-0228-3

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN： 1699-048X            Impact factor:   3.405


  14 in total

1.  Sarcoidlike reaction in patients with malignancy.

Authors:  A R Hunsaker; R F Munden; R D Pugatch; S J Mentzer
Journal:  Radiology       Date:  1996-07       Impact factor: 11.105

2.  Fluconazole for disseminated Cryptococcosis in a patient with Hodgkin's disease.

Authors:  P Iacopino; F Morabito; B Martino; G Bolignano; F Nobile
Journal:  Haematologica       Date:  1991 May-Jun       Impact factor: 9.941

3.  Cryptococcal meningitis in a patient with Hodgkin's lymphoma.

Authors:  K Rajkumar; T Rajkumar; T G Sagar; V Maitreyan; V Shanta
Journal:  J Assoc Physicians India       Date:  1992-10

4.  Vinblastine for recurrent Hodgkin's disease following autologous bone marrow transplant.

Authors:  R Little; R E Wittes; D L Longo; W H Wilson
Journal:  J Clin Oncol       Date:  1998-02       Impact factor: 44.544

5.  Bacterial infections in pediatric Hodgkin's disease: relationship to radiotherapy, chemotherapy and splenectomy.

Authors:  S S Donaldson; E Glatstein; K L Vosti
Journal:  Cancer       Date:  1978-05       Impact factor: 6.860

6.  Cryptococcal infection and lymphogranulomatous infiltration of the central nervous system in Hodgkin's disease.

Authors:  J Nowicka; G Mazur; K Kuliczkowski; A Gola; A Kochman; E Baran; B Walów
Journal:  Mycoses       Date:  1994 Nov-Dec       Impact factor: 4.377

7.  Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial.

Authors:  D C Linch; D Winfield; A H Goldstone; D Moir; B Hancock; A McMillan; R Chopra; D Milligan; G V Hudson
Journal:  Lancet       Date:  1993-04-24       Impact factor: 79.321

8.  Septicemia and meningitis in children splenectomized for hodgkin's disease.

Authors:  R R Chilcote; R L Baehner; D Hammond
Journal:  N Engl J Med       Date:  1976-10-07       Impact factor: 91.245

Review 9.  Hodgkin's lymphoma, Epstein-Barr virus reactivation and fatal haemophagocytic syndrome.

Authors:  S Hasselblom; A Linde; B Ridell
Journal:  J Intern Med       Date:  2004-02       Impact factor: 8.989

Review 10.  Pathogenesis of haemophagocytic lymphohistiocytosis.

Authors:  M Aricò; C Danesino; D Pende; L Moretta
Journal:  Br J Haematol       Date:  2001-09       Impact factor: 6.998
View more
  1 in total

1.  Disseminated cryptococcosis in a non-Hodgkin's lymphoma patient with late-onset neutropenia following rituximab-CHOP chemotherapy: a case report and literature review.

Authors:  Yuji Hirai; Yusuke Ainoda; Takayo Shoji; Takahiro Fujita; Kentaro Yoshinaga; Masayuki Shiseki; Naoki Mori; Masanao Teramura; Kyoichi Totsuka; Toshiko Motoji
Journal:  Mycopathologia       Date:  2011-04-07       Impact factor: 2.574
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.